GRFS
Price
$7.43
Change
-$0.62 (-7.70%)
Updated
Dec 18, 04:59 PM (EDT)
71 days until earnings call
SCLX
Price
$0.45
Change
-$0.05 (-10.00%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

GRFS vs SCLX

Header iconGRFS vs SCLX Comparison
Open Charts GRFS vs SCLXBanner chart's image
Grifols SA
Price$7.43
Change-$0.62 (-7.70%)
Volume$12K
CapitalizationN/A
Scilex Holding
Price$0.45
Change-$0.05 (-10.00%)
Volume$3.55K
CapitalizationN/A
GRFS vs SCLX Comparison Chart
Loading...
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRFS vs. SCLX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRFS is a Buy and SCLX is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (GRFS: $8.05 vs. SCLX: $0.50)
Brand notoriety: GRFS and SCLX are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GRFS: 114% vs. SCLX: 28%
Market capitalization -- GRFS: $5.48B vs. SCLX: $165.55M
GRFS [@Pharmaceuticals: Major] is valued at $5.48B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $165.55M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRFS’s FA Score shows that 1 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • GRFS’s FA Score: 1 green, 4 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, GRFS is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRFS’s TA Score shows that 5 TA indicator(s) are bullish while SCLX’s TA Score has 5 bullish TA indicator(s).

  • GRFS’s TA Score: 5 bullish, 5 bearish.
  • SCLX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SCLX is a better buy in the short-term than GRFS.

Price Growth

GRFS (@Pharmaceuticals: Major) experienced а +11.81% price change this week, while SCLX (@Pharmaceuticals: Major) price change was -12.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -2.43%. For the same industry, the average monthly price growth was -3.05%, and the average quarterly price growth was -1.91%.

Reported Earning Dates

GRFS is expected to report earnings on Feb 27, 2025.

SCLX is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Pharmaceuticals: Major (-2.43% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRFS($5.48B) has a higher market cap than SCLX($166M). GRFS YTD gains are higher at: -30.363 vs. SCLX (-75.270). GRFS has higher annual earnings (EBITDA): 640M vs. SCLX (-109.1M). GRFS has more cash in the bank: 544M vs. SCLX (3.92M). SCLX has less debt than GRFS: SCLX (128M) vs GRFS (11.1B). GRFS has higher revenues than SCLX: GRFS (6.54B) vs SCLX (46.7M).
GRFSSCLXGRFS / SCLX
Capitalization5.48B166M3,299%
EBITDA640M-109.1M-587%
Gain YTD-30.363-75.27040%
P/E Ratio68.68N/A-
Revenue6.54B46.7M13,994%
Total Cash544M3.92M13,874%
Total Debt11.1B128M8,672%
FUNDAMENTALS RATINGS
GRFS: Fundamental Ratings
GRFS
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
86
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRFSSCLX
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
49%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
45%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
39%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 10 days ago
67%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 7 days ago
22%
View a ticker or compare two or three
Ad is loading...
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARCM100.50N/A
N/A
Arrow Reserve Capital Management ETF
XMAR36.21-0.01
-0.03%
FT Vest U.S. Eq Enh & ModBufETF-Mar
PZA23.82-0.12
-0.50%
Invesco National AMT-Free Muni Bd ETF
LITP6.98-0.10
-1.41%
Sprott Lithium Miners ETF
URTY57.36-2.07
-3.48%
ProShares UltraPro Russell2000

GRFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRFS has been closely correlated with GIKLY. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GRFS jumps, then GIKLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRFS
1D Price
Change %
GRFS100%
+5.64%
GIKLY - GRFS
68%
Closely correlated
+2.19%
GIFOF - GRFS
37%
Loosely correlated
N/A
PFE - GRFS
28%
Poorly correlated
+4.67%
GIFLF - GRFS
23%
Poorly correlated
N/A
AMGN - GRFS
21%
Poorly correlated
-0.21%
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and AMRN have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and AMRN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
N/A
AMRN - SCLX
20%
Poorly correlated
-0.80%
OGN - SCLX
10%
Poorly correlated
+1.30%
BIIB - SCLX
10%
Poorly correlated
+0.10%
GRFS - SCLX
9%
Poorly correlated
+5.64%
RHHVF - SCLX
8%
Poorly correlated
+1.90%
More